{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:44:57Z","timestamp":1777290297441,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.arth.2022.02.102","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T02:23:35Z","timestamp":1646274215000},"page":"1326-1332.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study"],"prefix":"10.1016","volume":"37","author":[{"given":"Austin J.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailey J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-9729","authenticated-orcid":false,"given":"Olivia C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter W.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando L.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-5668","authenticated-orcid":false,"given":"William F.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2022.02.102_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2106\/JBJS.17.01617","article-title":"Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030","volume":"100","author":"Sloan","year":"2018","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.02.102_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.170990","article-title":"Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample","volume":"46","author":"Singh","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.arth.2022.02.102_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2106\/00004623-200405000-00012","article-title":"Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature","volume":"86","author":"Ethgen","year":"2004","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.02.102_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5435\/JAAOS-D-17-00210","article-title":"Outpatient total hip arthroplasty in the United States: a population-based comparative analysis of complication rates","volume":"27","author":"Arshi","year":"2019","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2022.02.102_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5371\/hp.2014.26.4.207","article-title":"Experience of complications of hip arthroplasty","volume":"26","author":"Hwang","year":"2014","journal-title":"Hip Pelvis"},{"key":"10.1016\/j.arth.2022.02.102_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.arth.2022.02.102_bib7","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Clinical practice. Chronic hepatitis C infection","volume":"364","author":"Rosen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2022.02.102_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.23736\/S0026-4806.20.07129-3","article-title":"Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management","volume":"112","author":"Nevola","year":"2021","journal-title":"Minerva Med"},{"key":"10.1016\/j.arth.2022.02.102_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bjps.2020.10.076","article-title":"The impact of hepatitis B and C diagnoses on surgical outcomes following mastectomy and breast reconstruction","volume":"74","author":"Oleru","year":"2021","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.arth.2022.02.102_bib10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2106\/JBJS.O.00183","article-title":"The impact of hepatitis C on short-term outcomes of total joint arthroplasty","volume":"97","author":"Issa","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.02.102_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.arth.2020.08.023","article-title":"Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty: an update","volume":"36","author":"Shapiro","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cld.783","article-title":"Epidemiology of hepatitis C","volume":"12","author":"Jafri","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.arth.2022.02.102_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep4.1457","article-title":"Hepatitis C virus prevalence in 50 U.S. States and D.C. By sex, birth cohort, and race: 2013-2016","volume":"4","author":"Bradley","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.arth.2022.02.102_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/2151458515583515","article-title":"The effect of advancing age on total joint replacement outcomes","volume":"6","author":"Fang","year":"2015","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"10.1016\/j.arth.2022.02.102_bib15","first-page":"102947","article-title":"Hepatitis C virus infection increases the risk of adverse outcomes following joint arthroplasty: a meta-analysis of observational studies","author":"Cheng","year":"2021","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.arth.2022.02.102_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/BOT.0000000000001286","article-title":"Hepatitis C is an independent risk factor for perioperative complications and nonroutine discharge in patients treated surgically for hip fractures","volume":"32","author":"Grau","year":"2018","journal-title":"J\u00a0Orthop Trauma"},{"key":"10.1016\/j.arth.2022.02.102_bib17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2106\/JBJS.J.00219","article-title":"Total joint arthroplasty in patients with hepatitis C","volume":"93","author":"Pour","year":"2011","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.02.102_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.arth.2018.09.036","article-title":"Treatment for chronic hepatitis C prior to total hip arthroplasty significantly reduces periprosthetic joint infection","volume":"34","author":"Bedair","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib19","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1016\/j.arth.2019.02.052","article-title":"Preoperative treatment of hepatitis C is associated with lower prosthetic joint infection rates in US veterans","volume":"34","author":"Bendich","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib20","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.arth.2019.06.058","article-title":"Undetectable hepatitis C viral load is associated with improved outcomes following total joint arthroplasty","volume":"34","author":"Novikov","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2007.03572.x","article-title":"The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases","volume":"27","author":"Kramer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arth.2022.02.102_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/pds.3721","article-title":"Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data","volume":"24","author":"Niu","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.arth.2022.02.102_bib23","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/580216","article-title":"Influence of healthcare-associated factors on the efficacy of hepatitis C therapy","volume":"2012","author":"Daw","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.arth.2022.02.102_bib24","doi-asserted-by":"crossref","first-page":"551500","DOI":"10.3389\/fphar.2020.551500","article-title":"Predicting treatment failure for initiators of hepatitis C virus treatment in the era of direct-acting antiviral therapy","volume":"11","author":"Nabulsi","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.arth.2022.02.102_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.arth.2022.02.102_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2022.02.102_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12913-020-05999-5","article-title":"Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data","volume":"21","author":"Sharma","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.arth.2022.02.102_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cgh.2019.05.047","article-title":"Gaps in viral hepatitis awareness in the United States in a population-based study","volume":"18","author":"Zhou","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arth.2022.02.102_bib29","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.25556","article-title":"Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008","volume":"55","author":"Denniston","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.arth.2022.02.102_bib30","series-title":"CDC","first-page":"1","article-title":"CDC recommendations for hepatitis C screening among adults \u2014 United States, 2020","author":"Schillie","year":"2020"},{"key":"10.1016\/j.arth.2022.02.102_bib31","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.5435\/JAAOS-D-16-00920","article-title":"Complication rates after total hip and knee arthroplasty in patients with hepatitis C compared with matched control patients","volume":"25","author":"Cancienne","year":"2017","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2022.02.102_bib32","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.arth.2017.10.061","article-title":"Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C","volume":"33","author":"Kildow","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jos.2018.12.026","article-title":"Does the hepatitis C virus affect the outcomes of total joint arthroplasty? A meta-analysis of ten studies","volume":"24","author":"Wei","year":"2019","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.arth.2022.02.102_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.arth.2014.11.013","article-title":"Increase in perioperative complications following primary total hip and knee arthroplasty in patients with hepatitis C without cirrhosis","volume":"30","author":"Best","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11999.0000000000000025","article-title":"Risk of complications after THA increases among patients who are coinfected with HIV and hepatitis C","volume":"476","author":"Mahure","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2022.02.102_bib36","doi-asserted-by":"crossref","first-page":"e2017019","DOI":"10.4084\/mjhid.2017.019","article-title":"Thrombocytopenia in patients with chronic hepatitis C virus infection","volume":"9","author":"Dahal","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.arth.2022.02.102_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2008.03.012","article-title":"Extrahepatic manifestations of hepatitis C virus infection","volume":"12","author":"Zignego","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.arth.2022.02.102_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.arth.2020.12.025","article-title":"Hepatitis C antiviral treatment decreases all-cause complications after total joint arthroplasty regardless of the presence of fibrosis","volume":"36","author":"Cornell","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jseint.2021.02.009","article-title":"Hepatitis C infection and complication rates after total shoulder arthroplasty in United States veterans","volume":"5","author":"Su","year":"2021","journal-title":"JSES Int"},{"key":"10.1016\/j.arth.2022.02.102_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.amjmed.2018.01.011","article-title":"Cigarette smoking in persons living with hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999-2014","volume":"131","author":"Kim","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.arth.2022.02.102_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/17453674.2019.1649510","article-title":"The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients","volume":"90","author":"Matharu","year":"2019","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2022.02.102_bib42","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.arth.2019.01.073","article-title":"Smoking cessation before and after total joint arthroplasty-an Uphill Battle","volume":"34","author":"Hart","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.02.102_bib43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.artd.2020.07.011","article-title":"Systematic review and meta-analysis of tobacco use as a risk factor for prosthetic joint infection after total hip replacement","volume":"6","author":"Bojan","year":"2020","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2022.02.102_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.artd.2021.05.021","article-title":"Failure to medically optimize before total hip arthroplasty: which modifiable risk factor is the most dangerous?","volume":"10","author":"Statz","year":"2021","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2022.02.102_bib45","doi-asserted-by":"crossref","DOI":"10.17305\/bjbms.2021.6538","article-title":"Impact of smoking on the incidence and postoperative complications of total knee arthroplasty: a systematic review and meta-analysis of cohort studies","author":"He","year":"2021","journal-title":"Bosn J Basic Med Sci"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:41:14Z","timestamp":1760121674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540322002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0883540322002534"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2022.02.102","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2022.02.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}